Abstract:The role of NADPH oxidase (NOX) was recently suggested in cardiac diseases including hypertrophy. Overexpression of a DN mutant of p67 phox , a cytosolic subunit of NOX, DN-p67 with a V204A point mutation completely inhibited NOX enzymatic function of superoxide generation. We found that overexpression of DN-p67 in cultured adult rat cardiac myocytes attenuated α 1 -adrenoceptor-induced hypertrophy , we thus hypothesized that NOX/p67 phox plays a critical role in cardiac hypertrophy and remodeling in vivo . Accordingly, we recently generated a Tg mouse model in C57BL/6 strain with cardiac-specific overexpression of this DN-p67 mutant along with an IRES-initiated EGFP tag protein using the cardiac-specific α-MHC promoter. Hearts from 1.5-, 3- and 6-month (M) old heterozygous Tg mice and their Non-Tg (NTg) littermates were harvested and compared. The heart weight/body weight (HW/BW) ratio in Tg group was significantly smaller (overall: 14%↓; 1.5-M: 10%↓; 3-M: 16%↓; 6-M: 12%↓) vs. the NTg group ( p < 0.01, n=23). This result was confirmed by 2D echocardiography (2D-echo) measuring the left ventricular myocardial area (LVMA) determined by subtracting endocardial area from epicardial area in short axis view at the end diastole. The LVMA (mm 2 ) in 3-M and 6-M mice was significantly ( p < 0.05, n=21) smaller in Tg (0.44±0.02) than the NTg (0.50±0.02) with equal average BW in both groups. LV internal dimensions and systolic function were preserved without difference in Tg vs. NTg. The LV wall thickness is smaller in Tg vs. NTg by both 2D-echo and hematoxylin/eosin staining of LV cross-sections, but no change in fibrosis was detected in both groups by trichrome staining (n=4). Interestingly, the expression of NOX catalytic subunit gp91 phox in Tg hearts was significantly decreased (~3-fold↓, n=5) vs. NTg by Western blot, whereas the cardiac expression of other NOX subunits p47 phox and p22 phox remained the same in both groups. In summary, we have generated a viable Tg mouse model with cardiac-specific overexpression of a DN p67 phox , which shows significant reduction in both myocardial mass/size and gp91 phox expression with normal cardiac function and development. Our results first show the novel and critical role of NOX/p67 phox in normal cardiac growth and heart development. This research has received full or partial funding support from the American Heart Association, AHA National Center.

Abstract 17040: Selective Inhibition of Myocardial NADPH Oxidase with a Dominant-Negative Mutant of P67 Phox Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Adult Transgenic Mice

Abstract 17329: Myocardial-Specific Overexpression of a Dominant-Negative Mutant of NADPH Oxidase Subunit P67 Phox Attenuates Pressure-Overload-Induced Cardiac Hypertrophy in Adult Transgenic Mice

Abstract 312: Selective Inhibition of Myocardial NADPH Oxidase Significantly Decreases Heart Size in Transgenic (tg) Mice with Cardiac-Specific Overexpression of a Dominant-Negative (DN) Mutant of P67 Phox

Overexpression of NOX2 Exacerbates AngII-Mediated Cardiac Dysfunction and Metabolic Remodelling

Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy

Knockdown of ANGPTL2 promotes left ventricular systolic dysfunction by upregulation of NOX4 in mice

Angiotensin-(1-7) Attenuates Angiotensin II-induced Cardiac Hypertrophy Via a Sirt3-dependent Mechanism.

The Role of Inos-Derived NO in the Antihypertrophic Actions of B-type Natriuretic Peptide in Neonatal Rat Cardiomyocytes

Human paraoxonase gene cluster overexpression alleviates angiotensin II-induced cardiac hypertrophy in mice

p47phox-Dependent Oxidant Signalling through ASK1, MKK3/6 and MAPKs in Angiotensin II-Induced Cardiac Hypertrophy and Apoptosis

Generation of a Transgenic (tg) Mouse Model with Cardiac Specific Overexpression of a Dominant Negative (DN) Mutant of P67phox

Enhanced Expression and Activity of Nox2 and Nox4 in the Macula Densa in ANG II-induced Hypertensive Mice.

Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.

Attenuation of AngII‐induced Early Cell Death by MT Results in a Prevention of the Late Development of Cardiomyopathy

Nitric Oxide Synthase Inhibition Abolishes Exercise-Mediated Protection Against Isoproterenol-Induced Cardiac Hypertrophy in Female Mice.

Reduced Hypertension-Induced End-Organ Damage in Mice Lacking Cardiac and Renal Angiotensinogen Synthesis.

[Molecular Mechanism of Nitric Oxide in Preventing Cardiomyocytes from Hypertrophic Response Induced by Angiotensin II].

Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy

Cardiac Ang Ⅱ and NADPH Oxdiase-derived ROS Are Involved in Pressure Overload-induced Cardiac Hypertrophy

Up-regulation of P27kip1 Contributes to Nrf2-mediated Protection Against Angiotensin II-induced Cardiac Hypertrophy

Cd38 Promotes Angiotensin Ii-Induced Cardiac Hypertrophy